Who We Are
Our Values Set Us Apart
At RegDev, integrity is our cornerstone, and we stand as a trusted partner in navigating the drug development regulatory process. With integrity as one of our guiding principles, we follow a systematic approach to provide strategic direction, leveraging a risk-based methodology as we embark on a collaborative journey with you.
OUR HISTORY
RegDev started as a small team in 2013 under the name Quality and Compliance Inc. As our service offers expanded, QCI rebranded to RegDev.
We grew quickly at the national/domestic US level and are now a global network of professionals. Our consultants are based throughout the US, Europe, and Asia.
Diversity is a core value. Women make up 81% of our team and 83% of our leadership team (where the industry average is only 50%).
The majority of our consultants have worked with us for over 6 years. This longevity allows for a broad level of expertise across disciplines and a depth of knowledge of the intricacies of the drug development process. Our teams know how to navigate the various processes, requirements, and regulations to help you achieve success for your product and your organization.
OUR GROWTH
We have had consistent growth as a company while helping support our clients throughout the drug approval process, generating $100B in revenue.
We have always believed in building a company embedded with strong ethical values. We strive to build an environment of mutual respect, trust, and integrity that helps our clients meet their challenges in an ethical and responsible manner. As a result, our consultants bring empathy, conscientiousness, and a desire to learn to every client partnership.
Our Values
Integrity
RegDev conducts business with the highest standards of integrity, striving for safe drug products and ensuring client’s sensitive information stays confidential. We earn the respect of one another and our clients by consistently demonstrating value, from how we treat one another to our high-quality drug development services and results.
Collaboration
RegDev’s team works well together and in conjunction with our client’s team, to help our clients achieve their goals. We are committed to working closely with our clients to build strong and long-term partnerships.
Social Responsibility
We believe in making the world a better place, whether that means striving to make drugs safer or giving back to our community.
MISSION AND VISION
OUR MISSION
RegDev’s mission is to be a trusted, forward-thinking partner. We guide our clients throughout the drug development lifecycle to support their success efficiently, reliably, and responsibly. We accomplish this through:
- Instilling an understanding and appreciation of the inherent importance of ethics and fostering a culture centered around quality
- Applying strategic, qualified, level-headed thinking
- Consistently and collaboratively helping our clients succeed, which contributes to improving the lives of patients
- Bringing the highest-quality, senior-level, solutions-driven teams, with profound knowledge and a breadth and depth of experience, to every relationship, new and existing
OUR VISION
RegDev’s vision is to build a healthier future together with our clients, empowering them to fully integrate, highest-caliber services and solutions. We accomplish this through:
- Involvement at the early stage as a strategic partner in drug development
- Leveraging RegDev’s industry-unique combination of deep-bench top-talent, collaborative culture, and proven ability to anticipate and navigate the drug development process for our clients
- Continually cultivating strong relationships, forward-thinking processes, and development of a highly knowledgeable and passionate team committed to future growth
News
Explore the latest industry trends and developments, regulatory updates, and insights, as well as the impactful work we’re doing here at RegDev.
-
How to Maximize Consultant Engagements
RegDev’s team of consultants are subject matter experts that partner with you to help you achieve your vision and goals. We want you to get the most out of your
Read More >
-
FDA Updates Guidance to Address Medical Misinformation
This revised guidance issued on July 8, 2024, replaces the 2014 draft guidance and is open for public comment for 60 days. Stay informed and help fight the spread of misinformation.
Read More >